Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,236,628
+$623,883 QoQ
Shares Held
20,810
-1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.12%
of 13F equity value
Holder Rank
#1,284
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARK SHEPTOFF FINANCIAL PLANNING, LLC holds $15,714,112 across 10 Drug Manufacturers - General names. ABBV ranks #2 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,538 | $8,263,675 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
20,810 | $5,236,628 | |
| 3 | LLY |
ELI LILLY & Co
|
705 | $845,598 | |
| 4 | NVS |
Novartis AG
|
5,120 | $802,406 | |
| 5 | PFE |
Pfizer Inc
|
12,734 | $306,634 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,000 | $172,860 | |
| 7 | MRK |
Merck & Co., Inc.
|
400 | $51,400 | |
| 8 | AMGN |
Amgen Inc
|
50 | $18,106 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,236,628 | 20,810 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,612,745 | 21,209 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,810,729 | 25,431 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,888,293 | 25,431 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,720,130 | 25,429 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $5,329,979 | 25,439 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,520,510 | 25,439 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,023,693 | 25,439 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,401,889 | 25,664 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,776,300 | 26,229 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $4,070,751 | 26,268 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,930,414 | 26,368 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,765,434 | 27,948 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,817,117 | 30,226 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,884,500 | 30,224 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,069,515 | 30,322 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,743,365 | 30,970 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,096,414 | 31,438 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,269,974 | 31,536 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,311,609 | 30,700 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,221,278 | 28,598 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,954,947 | 27,305 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,926,266 | 27,310 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,382,448 | 27,200 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,558,374 | 26,058 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,881,740 | 24,698 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||